It may be the end of the line for a popular decongestant. Pseudoephedrine, the mainstay decongestant in many over-the-counter cold and allergy medicines, is at the center of a national upheaval of the cough, cold and allergy category. As a result, products containing PSE may be near extinction, retailers and industry observers told SN. On March 9, the Combat Meth Act, embedded in the USA Patriot Act, was signed into law by President Bush, effectively limiting the amount of PSE products ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Registering for content on Supermarket News will give youINSTANTaccess to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’sFREE, easy and quick. What are you waiting for!In addition you will also receive complimentary access to the SN salary survey data tables.
Attention Paid Print Subscribers: While you have already been grantedfreeaccess to SNwe ask that youregister now.We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.